{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:25:12Z","timestamp":1790601912204,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.numecd.2024.08.006","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T01:30:39Z","timestamp":1723253439000},"page":"103712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7782-8949","authenticated-orcid":false,"given":"Chiara","family":"Tognola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0285-6038","authenticated-orcid":false,"given":"Rita Cristina","family":"Myriam Intravaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Senini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gualini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bellantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5720-320X","authenticated-orcid":false,"given":"Francesco","family":"Politi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Fucile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Mancusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3402-8859","authenticated-orcid":false,"given":"Enrica","family":"Golia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Giannattasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-6264","authenticated-orcid":false,"given":"Alessandro","family":"Maloberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.numecd.2024.08.006_bib1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jacc.2019.12.026","article-title":"Readmission and mortality after hospitalization for myocardial infarction and heart failure","volume":"75","author":"Ko","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.numecd.2024.08.006_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022198","article-title":"Event rates and risk factors for recurrent cardiovascular events and mortality in a contemporary post acute coronary syndrome population representing 239,234 patients during 2005 to 2018 in the United States","volume":"11","author":"Steen","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.numecd.2024.08.006_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11892-019-1178-6","article-title":"Extreme atherosclerotic cardiovascular disease (ASCVD) risk recognition","volume":"19","author":"Rosenblit","year":"2019","journal-title":"Curr Diabetes Rep"},{"issue":"1","key":"10.1016\/j.numecd.2024.08.006_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC Scientific Document Group. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.numecd.2024.08.006_bib5","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/eurheartj\/ehab771","article-title":"Extreme cardiovascular risk-do we need a new risk category?","volume":"43","author":"Dyrbu\u015b","year":"2022","journal-title":"Eur Heart J"},{"issue":"38","key":"10.1016\/j.numecd.2024.08.006_bib6","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"34","key":"10.1016\/j.numecd.2024.08.006_bib7","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.numecd.2024.08.006_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12471-020-01492-0","article-title":"Predictors of cardiac rehabilitation referral, enrolment and completion after acute myocardial infarction: an exploratory study","volume":"29","author":"Brouwers","year":"2021","journal-title":"Neth Heart J"},{"issue":"18","key":"10.1016\/j.numecd.2024.08.006_bib9","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.numecd.2024.08.006_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2024.08.006_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejim.2020.09.009","article-title":"Is the 2020 Sampson equation the best formula for LDL-C estimation?","volume":"83","author":"Piani","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.numecd.2024.08.006_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.numecd.2024.08.006_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s40292-023-00607-z","article-title":"Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-1), focus on prevalence and associated risk factors: the study protocol","volume":"30","author":"Maloberti","year":"2023","journal-title":"High Blood Pres Cardiovasc Prev 2023"},{"issue":"16","key":"10.1016\/j.numecd.2024.08.006_bib14","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.numecd.2024.08.006_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41569-019-0218-x","article-title":"RNA-based diagnostic and therapeutic strategies for cardiovascular disease","volume":"16","author":"Lu","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.numecd.2024.08.006_bib16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/CIR.0000000000000226","volume":"132","author":"Lindsey","year":"2015","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.numecd.2024.08.006_bib17","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/eurheartj\/ehac055","article-title":"Targeted proteomics improves cardiovascular risk prediction in secondary prevention","volume":"43","author":"Nurmohamed","year":"2022","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.numecd.2024.08.006_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005705","article-title":"Comprehensive metabolomic profiling and incident cardiovascular disease: a systematic review","volume":"6","author":"Ruiz-Canela","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.numecd.2024.08.006_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.numecd.2024.08.006_bib20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jama.2023.13258","article-title":"Evaluation of large-scale proteomics for prediction of cardiovascular events","volume":"330","author":"Helgason","year":"2023","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.numecd.2024.08.006_bib21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s11886-023-01995-3","article-title":"Multi-proteomic biomarker risk scores for predicting risk and guiding therapy in patients with coronary artery disease","volume":"25","author":"Gold","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.numecd.2024.08.006_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.amjcard.2023.06.115","article-title":"Aggregate clinical and biomarker-based model predicts adverse outcomes in patients with coronary artery disease","volume":"203","author":"Desai","year":"2023","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2024.08.006_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"REDUCE-IT investigators. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"10106","key":"10.1016\/j.numecd.2024.08.006_bib24","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.numecd.2024.08.006_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12933-022-01575-9","article-title":"Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes","volume":"21","author":"Davies","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.numecd.2024.08.006_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jamaneurol.2019.2984","article-title":"Association between low-dose rivaroxaban with or without aspirin and ischemic stroke subtypes: a secondary analysis of the compass trial","volume":"77","author":"Perera","year":"2020","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.numecd.2024.08.006_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.15420\/ecr.2017:23:9","article-title":"Does Angiotensin receptor neprilysin inhibitor (ARNI) improve functional capacity assessed by 6 minutes walking test?","volume":"12","author":"Faraudo","year":"2017","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.numecd.2024.08.006_bib28","article-title":"Effects of sacubitril valsartan on clinical and echocardiographic parameters of outpatients with heart failure and reduced ejection fraction","volume":"31","author":"Landolfo","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"4","key":"10.1016\/j.numecd.2024.08.006_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/clc.22899","article-title":"Early effects of empagliflozin on exercise tolerance in patients with heart failure: a pilot study","volume":"41","author":"N\u00fa\u00f1ez","year":"2018","journal-title":"Clin Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2024.08.006_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40292-021-00473-7","article-title":"Determinants of functional improvement after cardiac rehabilitation in acute coronary syndrome","volume":"28","author":"Bianchi","year":"2021","journal-title":"High Blood Pres Cardiovasc Prev"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532400303X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532400303X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T06:27:24Z","timestamp":1740292044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093947532400303X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S093947532400303X"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2024.08.006","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2024.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"103712"}}